Delivery Order SPE2DR25D1100-SPE2DR26FCS7C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,695.88 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,169.62 and an ultimate completion date of September 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) valued at $1,464.52 under a firm fixed-price contract. The delivery order, issued on September 26, 2025, requires completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,774.63 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count packaging). This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $1,045.22 for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract, awarded on December 3, 2025, with a completion date of December 4, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Terbinafine HCL 250 mg tablets in a quantity of 30 units, with a contract ceiling value of $8,444.30. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,370.30 and an ultimate completion date of December 3, 2025. The contract is non-set-aside and was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,784.72 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (90-count) on November 24, 2025, with an ultimate completion date of November 25, 2025. This is a firm fixed price, non-set-aside contract with performance conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS7CDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,706.98 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract was awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive procurement action consistent with the company's established role as a critical pharmaceutical vendor for federal medical supply needs. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. Through this contract vehicle, the company provides pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/2/25 |